

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.61977305 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.61977305 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.45334842 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96387370 |
| 5 | detection of other organism (GO:0098543) | 4.52467032 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.50619859 |
| 7 | detection of bacterium (GO:0016045) | 4.45649574 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.00453722 |
| 9 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.90925091 |
| 10 | detection of external biotic stimulus (GO:0098581) | 3.79144674 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.77240216 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.73176152 |
| 13 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.65895802 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 3.63902988 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 3.62195109 |
| 16 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.54973300 |
| 17 | germinal center formation (GO:0002467) | 3.52052797 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.49862596 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 3.45638738 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 3.41080557 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.34637974 |
| 22 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.34158908 |
| 23 | negative regulation of T cell mediated immunity (GO:0002710) | 3.30753632 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.30535920 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.30535920 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.30535920 |
| 27 | positive regulation by symbiont of host defense response (GO:0052509) | 3.30535920 |
| 28 | modulation by symbiont of host defense response (GO:0052031) | 3.30535920 |
| 29 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.30535920 |
| 30 | detection of biotic stimulus (GO:0009595) | 3.28627763 |
| 31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.21929446 |
| 32 | response to host immune response (GO:0052572) | 3.21929446 |
| 33 | regulation of B cell differentiation (GO:0045577) | 3.20524175 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.20206206 |
| 35 | positive thymic T cell selection (GO:0045059) | 3.20112710 |
| 36 | negative thymic T cell selection (GO:0045060) | 3.19952266 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.13599262 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.12460612 |
| 39 | response to host (GO:0075136) | 3.12460612 |
| 40 | response to host defenses (GO:0052200) | 3.12460612 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.12221006 |
| 42 | regulation of tolerance induction (GO:0002643) | 3.12028555 |
| 43 | negative T cell selection (GO:0043383) | 3.11301329 |
| 44 | regulation of mast cell degranulation (GO:0043304) | 3.10950018 |
| 45 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.10819249 |
| 46 | leukocyte aggregation (GO:0070486) | 3.05175863 |
| 47 | negative regulation of cell killing (GO:0031342) | 3.02586481 |
| 48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.02586481 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02288397 |
| 50 | NIK/NF-kappaB signaling (GO:0038061) | 2.99814086 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.98627849 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 2.95676933 |
| 53 | response to type I interferon (GO:0034340) | 2.94336020 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92503406 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 2.92069430 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.91256846 |
| 57 | response to muramyl dipeptide (GO:0032495) | 2.91254255 |
| 58 | cellular response to type I interferon (GO:0071357) | 2.89641162 |
| 59 | type I interferon signaling pathway (GO:0060337) | 2.89641162 |
| 60 | negative regulation of innate immune response (GO:0045824) | 2.88552866 |
| 61 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87390789 |
| 62 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.85265518 |
| 63 | macrophage activation (GO:0042116) | 2.84462739 |
| 64 | regulation of T cell tolerance induction (GO:0002664) | 2.82466743 |
| 65 | cellular response to zinc ion (GO:0071294) | 2.80863012 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80729520 |
| 67 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80564587 |
| 68 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80226951 |
| 69 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79710367 |
| 70 | mannose metabolic process (GO:0006013) | 2.79526328 |
| 71 | macrophage activation involved in immune response (GO:0002281) | 2.76166028 |
| 72 | B cell receptor signaling pathway (GO:0050853) | 2.76116403 |
| 73 | cellular extravasation (GO:0045123) | 2.75644264 |
| 74 | microglial cell activation (GO:0001774) | 2.75351385 |
| 75 | response to peptidoglycan (GO:0032494) | 2.74991681 |
| 76 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.73598772 |
| 77 | positive regulation of tolerance induction (GO:0002645) | 2.73116246 |
| 78 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.71019846 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.70576908 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.70182313 |
| 81 | myeloid dendritic cell activation (GO:0001773) | 2.69312436 |
| 82 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.69040042 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.69040042 |
| 84 | thymic T cell selection (GO:0045061) | 2.67791748 |
| 85 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.67644519 |
| 86 | respiratory burst (GO:0045730) | 2.67252749 |
| 87 | negative regulation of phagocytosis (GO:0050765) | 2.67251333 |
| 88 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.66248870 |
| 89 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.66248870 |
| 90 | regulation of cholesterol storage (GO:0010885) | 2.63235023 |
| 91 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.63131541 |
| 92 | positive regulation of type 2 immune response (GO:0002830) | 2.62218536 |
| 93 | negative regulation of granulocyte differentiation (GO:0030853) | 2.61790272 |
| 94 | leukocyte cell-cell adhesion (GO:0007159) | 2.61587040 |
| 95 | pinocytosis (GO:0006907) | 2.60967445 |
| 96 | interferon-gamma production (GO:0032609) | 2.60913873 |
| 97 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59659651 |
| 98 | response to interleukin-15 (GO:0070672) | 2.58913115 |
| 99 | negative regulation of interleukin-12 production (GO:0032695) | 2.57900496 |
| 100 | regulation of antigen processing and presentation (GO:0002577) | 2.57877653 |
| 101 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.57568994 |
| 102 | positive regulation of interferon-beta production (GO:0032728) | 2.55561184 |
| 103 | myeloid dendritic cell differentiation (GO:0043011) | 2.55451103 |
| 104 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.55382857 |
| 105 | regulation of response to interferon-gamma (GO:0060330) | 2.55312441 |
| 106 | neutrophil activation (GO:0042119) | 2.54978997 |
| 107 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.54018606 |
| 108 | T cell migration (GO:0072678) | 2.53447123 |
| 109 | B cell mediated immunity (GO:0019724) | 2.52208478 |
| 110 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.52007969 |
| 111 | tolerance induction (GO:0002507) | 2.52001840 |
| 112 | cellular response to exogenous dsRNA (GO:0071360) | 2.50934524 |
| 113 | hepatocyte apoptotic process (GO:0097284) | 2.49806481 |
| 114 | natural killer cell differentiation (GO:0001779) | 2.49412831 |
| 115 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48243821 |
| 116 | low-density lipoprotein particle clearance (GO:0034383) | 2.47727479 |
| 117 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.47062276 |
| 118 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.43448795 |
| 119 | positive regulation of humoral immune response (GO:0002922) | 2.43189444 |
| 120 | granulocyte activation (GO:0036230) | 2.42779949 |
| 121 | regulation of natural killer cell differentiation (GO:0032823) | 2.38711374 |
| 122 | T cell selection (GO:0045058) | 2.38369231 |
| 123 | response to protozoan (GO:0001562) | 2.36151844 |
| 124 | response to laminar fluid shear stress (GO:0034616) | 2.32937555 |
| 125 | positive regulation of interleukin-2 production (GO:0032743) | 2.32242894 |
| 126 | defense response to protozoan (GO:0042832) | 2.31833931 |
| 127 | growth hormone receptor signaling pathway (GO:0060396) | 2.31173854 |
| 128 | myeloid cell activation involved in immune response (GO:0002275) | 2.30716398 |
| 129 | positive regulation of defense response to virus by host (GO:0002230) | 2.29865226 |
| 130 | T cell homeostasis (GO:0043029) | 2.27787392 |
| 131 | positive regulation of histone deacetylation (GO:0031065) | 2.27229207 |
| 132 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.27176194 |
| 133 | positive regulation of macrophage differentiation (GO:0045651) | 2.26952000 |
| 134 | T cell proliferation (GO:0042098) | 2.26875420 |
| 135 | JAK-STAT cascade (GO:0007259) | 2.26814089 |
| 136 | positive T cell selection (GO:0043368) | 2.26732382 |
| 137 | negative regulation of lipid storage (GO:0010888) | 2.26176608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.61646081 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.22596370 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.88997207 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.83392073 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.81542197 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.10302828 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.95111330 |
| 8 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.89174920 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86108514 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.85420091 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80566344 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79489311 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71675499 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.61712913 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44490328 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.38816196 |
| 17 | * MYC_22102868_ChIP-Seq_BL_Human | 2.31650479 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.29657836 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.29295625 |
| 20 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23985031 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21331835 |
| 22 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.21102628 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15669767 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14296725 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.07936101 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07878916 |
| 27 | * MAF_26560356_Chip-Seq_TH1_Human | 2.07333266 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.00999917 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97466895 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97448796 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96076760 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.95760304 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90441510 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.89459884 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89138372 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.87037789 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86338386 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.84959952 |
| 39 | * MYB_26560356_Chip-Seq_TH1_Human | 1.79518693 |
| 40 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.77519853 |
| 41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.75148109 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73030500 |
| 43 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.72713043 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70977482 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70093679 |
| 46 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.66511327 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66202556 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55575129 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54777543 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52321898 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51181808 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47929458 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46037821 |
| 54 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45360812 |
| 55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38825712 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37249236 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33616647 |
| 58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32380222 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31771144 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30846546 |
| 61 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29039053 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28555897 |
| 63 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28094218 |
| 64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26935013 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26192195 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25669021 |
| 67 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24669056 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21549399 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20997009 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20823211 |
| 71 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20548939 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.20357318 |
| 73 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19977643 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19737538 |
| 75 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19466486 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19299383 |
| 77 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19279019 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18237731 |
| 79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18180586 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17732008 |
| 81 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.16776855 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15830175 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13381824 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11644209 |
| 85 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11103810 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11081231 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09922613 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09330112 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08297359 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07818218 |
| 91 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07374382 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06980500 |
| 93 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03488172 |
| 94 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02223726 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02108655 |
| 96 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.00384702 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00324297 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99849462 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99207798 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98348306 |
| 101 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98020853 |
| 102 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97989258 |
| 103 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97558798 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97224538 |
| 105 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97119099 |
| 106 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96516934 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95626676 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95342313 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95269122 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94780013 |
| 111 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94081981 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94081981 |
| 113 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92125067 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92048248 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91942200 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91926821 |
| 117 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.90995893 |
| 118 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90394298 |
| 119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90282380 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89785069 |
| 121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89347622 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89292715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 3.46281456 |
| 2 | MP0003436_decreased_susceptibility_to | 2.98993538 |
| 3 | MP0000685_abnormal_immune_system | 2.71000718 |
| 4 | MP0009785_altered_susceptibility_to | 2.57814013 |
| 5 | MP0005387_immune_system_phenotype | 2.49629156 |
| 6 | MP0001790_abnormal_immune_system | 2.49629156 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.38382397 |
| 8 | * MP0001800_abnormal_humoral_immune | 2.37864354 |
| 9 | * MP0005000_abnormal_immune_tolerance | 2.36567759 |
| 10 | MP0005671_abnormal_response_to | 2.31561387 |
| 11 | MP0002419_abnormal_innate_immunity | 2.29710887 |
| 12 | * MP0005025_abnormal_response_to | 2.23374019 |
| 13 | MP0003724_increased_susceptibility_to | 2.23190090 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.22798824 |
| 15 | MP0003303_peritoneal_inflammation | 2.14011715 |
| 16 | * MP0002723_abnormal_immune_serum | 2.06717397 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.05131574 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.00621831 |
| 19 | MP0005464_abnormal_platelet_physiology | 1.98973799 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 1.97612314 |
| 21 | * MP0001819_abnormal_immune_cell | 1.96793480 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.94490526 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.94249144 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.90027558 |
| 25 | MP0002396_abnormal_hematopoietic_system | 1.86432297 |
| 26 | MP0005451_abnormal_body_composition | 1.85647037 |
| 27 | * MP0002405_respiratory_system_inflammati | 1.84029169 |
| 28 | * MP0004947_skin_inflammation | 1.83897718 |
| 29 | MP0008260_abnormal_autophagy | 1.82979215 |
| 30 | MP0006082_CNS_inflammation | 1.82774015 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.81434742 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.65990849 |
| 33 | * MP0002398_abnormal_bone_marrow | 1.65735451 |
| 34 | MP0001853_heart_inflammation | 1.65495528 |
| 35 | MP0004510_myositis | 1.62443542 |
| 36 | * MP0000716_abnormal_immune_system | 1.62342418 |
| 37 | MP0001873_stomach_inflammation | 1.62229272 |
| 38 | MP0009840_abnormal_foam_cell | 1.61870986 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.61410818 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.61220095 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.59344873 |
| 42 | MP0002006_tumorigenesis | 1.55770044 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.53738473 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.52777201 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.51832304 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.50778317 |
| 47 | MP0004381_abnormal_hair_follicle | 1.49039179 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.46583762 |
| 49 | MP0009278_abnormal_bone_marrow | 1.45528664 |
| 50 | MP0000858_altered_metastatic_potential | 1.44256163 |
| 51 | MP0002722_abnormal_immune_system | 1.44154434 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.42954819 |
| 53 | MP0008469_abnormal_protein_level | 1.40268680 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.40100148 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.38319870 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.38319870 |
| 57 | MP0009764_decreased_sensitivity_to | 1.37540006 |
| 58 | * MP0002429_abnormal_blood_cell | 1.36650162 |
| 59 | MP0002254_reproductive_system_inflammat | 1.35476599 |
| 60 | MP0005360_urolithiasis | 1.30929016 |
| 61 | MP0003448_altered_tumor_morphology | 1.29915260 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 1.29652597 |
| 63 | MP0002933_joint_inflammation | 1.23377643 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.23185868 |
| 65 | MP0005023_abnormal_wound_healing | 1.19844402 |
| 66 | MP0000343_altered_response_to | 1.19601446 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 1.19588105 |
| 68 | MP0004883_abnormal_blood_vessel | 1.15935939 |
| 69 | MP0005164_abnormal_response_to | 1.07137035 |
| 70 | MP0002139_abnormal_hepatobiliary_system | 1.05370165 |
| 71 | MP0000609_abnormal_liver_physiology | 1.04925999 |
| 72 | MP0000703_abnormal_thymus_morphology | 1.04004392 |
| 73 | MP0000604_amyloidosis | 1.03325116 |
| 74 | MP0003866_abnormal_defecation | 1.01154287 |
| 75 | MP0003091_abnormal_cell_migration | 1.00321646 |
| 76 | MP0009763_increased_sensitivity_to | 1.00192419 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.00020154 |
| 78 | MP0003828_pulmonary_edema | 0.99806788 |
| 79 | MP0003279_aneurysm | 0.99696734 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.99688733 |
| 81 | MP0003075_altered_response_to | 0.97800370 |
| 82 | MP0005310_abnormal_salivary_gland | 0.97632485 |
| 83 | MP0003045_fibrosis | 0.96373553 |
| 84 | MP0000490_abnormal_crypts_of | 0.94390337 |
| 85 | MP0008004_abnormal_stomach_pH | 0.92890071 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.91308380 |
| 87 | MP0005166_decreased_susceptibility_to | 0.90708873 |
| 88 | MP0001958_emphysema | 0.90025754 |
| 89 | MP0010307_abnormal_tumor_latency | 0.87482996 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.87233249 |
| 91 | MP0001849_ear_inflammation | 0.86931586 |
| 92 | MP0001663_abnormal_digestive_system | 0.86506907 |
| 93 | MP0000249_abnormal_blood_vessel | 0.85960917 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.85760349 |
| 95 | MP0001243_abnormal_dermal_layer | 0.82398124 |
| 96 | MP0005365_abnormal_bile_salt | 0.80458058 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.79972105 |
| 98 | MP0004130_abnormal_muscle_cell | 0.79778574 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.79360370 |
| 100 | MP0001851_eye_inflammation | 0.78937040 |
| 101 | MP0005390_skeleton_phenotype | 0.78566604 |
| 102 | MP0003252_abnormal_bile_duct | 0.78465968 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.78211428 |
| 104 | MP0002060_abnormal_skin_morphology | 0.78079594 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.77075662 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 0.76768618 |
| 107 | MP0005670_abnormal_white_adipose | 0.76656642 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.76432124 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.76289660 |
| 110 | MP0003795_abnormal_bone_structure | 0.75841596 |
| 111 | MP0000598_abnormal_liver_morphology | 0.74905561 |
| 112 | MP0000371_diluted_coat_color | 0.73848378 |
| 113 | MP0003690_abnormal_glial_cell | 0.73132362 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.72386093 |
| 115 | MP0005409_darkened_coat_color | 0.69254754 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.62641403 |
| 117 | MP0004264_abnormal_extraembryonic_tissu | 0.61492425 |
| 118 | MP0001348_abnormal_lacrimal_gland | 0.61164737 |
| 119 | MP0009115_abnormal_fat_cell | 0.60042178 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.59092309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.78486959 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.26828303 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.95839335 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52999764 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.43123277 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 3.39907372 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.37963026 |
| 8 | Myositis (HP:0100614) | 3.30841056 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.26533127 |
| 10 | Recurrent viral infections (HP:0004429) | 3.26439508 |
| 11 | Chronic otitis media (HP:0000389) | 3.04966255 |
| 12 | Periodontitis (HP:0000704) | 3.02144338 |
| 13 | Spontaneous hematomas (HP:0007420) | 2.95286413 |
| 14 | Pustule (HP:0200039) | 2.92796051 |
| 15 | Encephalitis (HP:0002383) | 2.91937014 |
| 16 | Myocardial infarction (HP:0001658) | 2.87658273 |
| 17 | Keratoconjunctivitis sicca (HP:0001097) | 2.84158594 |
| 18 | Interstitial pulmonary disease (HP:0006530) | 2.83322727 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 2.83041045 |
| 20 | Recurrent skin infections (HP:0001581) | 2.81760937 |
| 21 | Cellulitis (HP:0100658) | 2.78825788 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 2.78550052 |
| 23 | Abnormality of the nasal mucosa (HP:0000433) | 2.77438253 |
| 24 | Orchitis (HP:0100796) | 2.71161307 |
| 25 | Abnormality of macrophages (HP:0004311) | 2.70584856 |
| 26 | Nasal polyposis (HP:0100582) | 2.66572016 |
| 27 | Vasculitis (HP:0002633) | 2.65132776 |
| 28 | Recurrent bronchitis (HP:0002837) | 2.64678060 |
| 29 | Hematochezia (HP:0002573) | 2.64442578 |
| 30 | Thrombocytosis (HP:0001894) | 2.63859303 |
| 31 | IgM deficiency (HP:0002850) | 2.59336815 |
| 32 | Colitis (HP:0002583) | 2.58495577 |
| 33 | Arterial thrombosis (HP:0004420) | 2.58370728 |
| 34 | Osteolytic defects of the hand bones (HP:0009699) | 2.58010869 |
| 35 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.58010869 |
| 36 | Abnormality of T cell number (HP:0011839) | 2.56390531 |
| 37 | Keratoconjunctivitis (HP:0001096) | 2.55486817 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 2.54665174 |
| 39 | Inflammation of the large intestine (HP:0002037) | 2.50491825 |
| 40 | Meningitis (HP:0001287) | 2.50308401 |
| 41 | T lymphocytopenia (HP:0005403) | 2.49138383 |
| 42 | Abnormal platelet volume (HP:0011876) | 2.46889282 |
| 43 | Complement deficiency (HP:0004431) | 2.46643435 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46430811 |
| 45 | Glomerulonephritis (HP:0000099) | 2.46271909 |
| 46 | Epistaxis (HP:0000421) | 2.46089148 |
| 47 | Stomatitis (HP:0010280) | 2.45249886 |
| 48 | Gingival bleeding (HP:0000225) | 2.44853051 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.44630083 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.40774979 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.40774979 |
| 52 | Gingivitis (HP:0000230) | 2.37524384 |
| 53 | Abnormality of complement system (HP:0005339) | 2.36128465 |
| 54 | Malnutrition (HP:0004395) | 2.34046437 |
| 55 | Amyloidosis (HP:0011034) | 2.31751692 |
| 56 | Abnormality of the prostate (HP:0008775) | 2.31092576 |
| 57 | Increased mean platelet volume (HP:0011877) | 2.31081238 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 2.29205415 |
| 59 | Abnormality of T cells (HP:0002843) | 2.28113180 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.27404971 |
| 61 | Optic neuritis (HP:0100653) | 2.23095417 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.23095417 |
| 63 | Agammaglobulinemia (HP:0004432) | 2.21741533 |
| 64 | Restrictive lung disease (HP:0002091) | 2.21089082 |
| 65 | Osteomyelitis (HP:0002754) | 2.20961284 |
| 66 | Leukocytosis (HP:0001974) | 2.20740368 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.20346004 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18521627 |
| 69 | Mucopolysacchariduria (HP:0008155) | 2.18521627 |
| 70 | Hypochromic anemia (HP:0001931) | 2.18518094 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.17717386 |
| 72 | Aortic aneurysm (HP:0004942) | 2.17151622 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.16246049 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.15433908 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.15433908 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.15433908 |
| 77 | Abnormality of the peritoneum (HP:0002585) | 2.13968441 |
| 78 | Obstructive lung disease (HP:0006536) | 2.13517520 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13517520 |
| 80 | Abnormal platelet function (HP:0011869) | 2.13106741 |
| 81 | Impaired platelet aggregation (HP:0003540) | 2.13106741 |
| 82 | Purpura (HP:0000979) | 2.12971970 |
| 83 | Peritonitis (HP:0002586) | 2.12889281 |
| 84 | Joint hemorrhage (HP:0005261) | 2.11144658 |
| 85 | Nephritis (HP:0000123) | 2.10838256 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.10195019 |
| 87 | Prostate neoplasm (HP:0100787) | 2.09792876 |
| 88 | Eosinophilia (HP:0001880) | 2.09073606 |
| 89 | Petechiae (HP:0000967) | 2.08273388 |
| 90 | IgA deficiency (HP:0002720) | 2.08088380 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 2.07883192 |
| 92 | Premature loss of primary teeth (HP:0006323) | 2.07663723 |
| 93 | Abnormality of the pleura (HP:0002103) | 2.07061775 |
| 94 | Spondylolisthesis (HP:0003302) | 2.06996784 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06932073 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06932073 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06932073 |
| 98 | Viral hepatitis (HP:0006562) | 2.06445762 |
| 99 | Hemoptysis (HP:0002105) | 2.05587853 |
| 100 | Emphysema (HP:0002097) | 2.05432905 |
| 101 | Increased IgM level (HP:0003496) | 2.04394760 |
| 102 | Sepsis (HP:0100806) | 2.03934409 |
| 103 | Gastrointestinal stroma tumor (HP:0100723) | 2.03721202 |
| 104 | Esophageal varix (HP:0002040) | 2.02746942 |
| 105 | Lymphopenia (HP:0001888) | 2.02173692 |
| 106 | Loss of speech (HP:0002371) | 2.01770844 |
| 107 | Increased IgE level (HP:0003212) | 2.01458744 |
| 108 | Verrucae (HP:0200043) | 2.01395352 |
| 109 | Papilloma (HP:0012740) | 2.01395352 |
| 110 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99851266 |
| 111 | Skin ulcer (HP:0200042) | 1.99476729 |
| 112 | Granulocytopenia (HP:0001913) | 1.96867384 |
| 113 | Chronic diarrhea (HP:0002028) | 1.95982198 |
| 114 | Episodic fever (HP:0001954) | 1.95611958 |
| 115 | Absent frontal sinuses (HP:0002688) | 1.95246300 |
| 116 | Pulmonary embolism (HP:0002204) | 1.94978182 |
| 117 | Polygenic inheritance (HP:0010982) | 1.94250619 |
| 118 | Persistence of primary teeth (HP:0006335) | 1.94058789 |
| 119 | Urticaria (HP:0001025) | 1.92778129 |
| 120 | Hemorrhage of the eye (HP:0011885) | 1.92512811 |
| 121 | Anorexia (HP:0002039) | 1.92283010 |
| 122 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.91954547 |
| 123 | Spinal cord lesions (HP:0100561) | 1.91784309 |
| 124 | Syringomyelia (HP:0003396) | 1.91784309 |
| 125 | Gangrene (HP:0100758) | 1.91573381 |
| 126 | Cerebral aneurysm (HP:0004944) | 1.91151491 |
| 127 | Chest pain (HP:0100749) | 1.90575705 |
| 128 | Joint swelling (HP:0001386) | 1.90559139 |
| 129 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89750940 |
| 130 | Recurrent sinusitis (HP:0011108) | 1.88793081 |
| 131 | Abnormality of the fingertips (HP:0001211) | 1.86219519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.65331349 |
| 2 | PRPF4B | 3.05829223 |
| 3 | JAK3 | 2.91096423 |
| 4 | TYK2 | 2.68156980 |
| 5 | MAP3K14 | 2.53032534 |
| 6 | ERN1 | 2.46575507 |
| 7 | TGFBR2 | 2.34985439 |
| 8 | TRIB3 | 2.33697786 |
| 9 | TBK1 | 2.25769215 |
| 10 | BLK | 2.22935312 |
| 11 | STK10 | 2.22126710 |
| 12 | ZAP70 | 2.09910556 |
| 13 | MAP2K3 | 2.05280600 |
| 14 | PKN2 | 2.01805438 |
| 15 | TXK | 1.89042436 |
| 16 | KIT | 1.87766644 |
| 17 | FGFR4 | 1.83453702 |
| 18 | IRAK3 | 1.82736446 |
| 19 | IKBKE | 1.79971152 |
| 20 | TAOK3 | 1.78870388 |
| 21 | IKBKB | 1.73814039 |
| 22 | JAK1 | 1.72099717 |
| 23 | TTN | 1.71662408 |
| 24 | TNK2 | 1.71379476 |
| 25 | ITK | 1.70074514 |
| 26 | TEC | 1.67429975 |
| 27 | IRAK4 | 1.64105164 |
| 28 | SIK1 | 1.62098985 |
| 29 | EEF2K | 1.61766642 |
| 30 | BTK | 1.59155450 |
| 31 | LRRK2 | 1.55577235 |
| 32 | MAP3K10 | 1.54028854 |
| 33 | SMG1 | 1.47319273 |
| 34 | CHUK | 1.39306112 |
| 35 | EPHB1 | 1.39243314 |
| 36 | CSK | 1.38683604 |
| 37 | RPS6KA4 | 1.33868171 |
| 38 | SYK | 1.33816782 |
| 39 | CSF1R | 1.33612149 |
| 40 | MAP3K3 | 1.32845890 |
| 41 | CDC42BPA | 1.32519822 |
| 42 | NEK9 | 1.32278938 |
| 43 | NME2 | 1.28490094 |
| 44 | FGFR3 | 1.25129731 |
| 45 | RIPK4 | 1.24026551 |
| 46 | FLT3 | 1.22559515 |
| 47 | MAP3K1 | 1.16973657 |
| 48 | MARK2 | 1.16580248 |
| 49 | PTK6 | 1.16008791 |
| 50 | GRK6 | 1.15927924 |
| 51 | PRKD2 | 1.14486681 |
| 52 | KDR | 1.13471396 |
| 53 | HCK | 1.11862277 |
| 54 | LCK | 1.09571066 |
| 55 | JAK2 | 1.06005483 |
| 56 | PIM1 | 1.04846728 |
| 57 | CAMK1D | 1.02559653 |
| 58 | MST1R | 0.99989887 |
| 59 | RIPK1 | 0.99545389 |
| 60 | CLK1 | 0.94608518 |
| 61 | TRPM7 | 0.93663709 |
| 62 | MAP3K13 | 0.90827975 |
| 63 | EPHA3 | 0.89930270 |
| 64 | MST4 | 0.89077240 |
| 65 | TAOK2 | 0.86254824 |
| 66 | MAP3K6 | 0.85955072 |
| 67 | HIPK2 | 0.85729568 |
| 68 | KSR2 | 0.85027180 |
| 69 | NLK | 0.84839253 |
| 70 | PIM2 | 0.84712102 |
| 71 | MAPK7 | 0.82350095 |
| 72 | PDPK1 | 0.82304067 |
| 73 | MAP3K11 | 0.81647173 |
| 74 | CDK9 | 0.80104889 |
| 75 | LYN | 0.76653852 |
| 76 | MARK3 | 0.75213805 |
| 77 | TGFBR1 | 0.74158426 |
| 78 | MAPK12 | 0.73660076 |
| 79 | TAOK1 | 0.70729066 |
| 80 | BMPR2 | 0.70179699 |
| 81 | CDK6 | 0.69850340 |
| 82 | IRAK1 | 0.69630067 |
| 83 | YES1 | 0.65738664 |
| 84 | STK4 | 0.60637669 |
| 85 | MATK | 0.59604709 |
| 86 | CDK4 | 0.58438696 |
| 87 | FGR | 0.58223610 |
| 88 | TESK2 | 0.58003514 |
| 89 | MAP3K7 | 0.57213989 |
| 90 | ICK | 0.55188311 |
| 91 | IRAK2 | 0.54359457 |
| 92 | MAP3K8 | 0.53610187 |
| 93 | FYN | 0.53381511 |
| 94 | MAPKAPK3 | 0.53380460 |
| 95 | PAK4 | 0.50818956 |
| 96 | BMX | 0.50569831 |
| 97 | MAPK11 | 0.50234206 |
| 98 | EGFR | 0.49708955 |
| 99 | SIK2 | 0.49632489 |
| 100 | MAP3K2 | 0.49507181 |
| 101 | MAPKAPK2 | 0.48741104 |
| 102 | PIK3CA | 0.48376432 |
| 103 | PDGFRB | 0.48371224 |
| 104 | STK3 | 0.47922188 |
| 105 | RET | 0.46681964 |
| 106 | RPS6KA2 | 0.46506717 |
| 107 | ABL1 | 0.46295712 |
| 108 | RPS6KA6 | 0.46113226 |
| 109 | STK38 | 0.45461308 |
| 110 | MAP2K6 | 0.44090932 |
| 111 | FES | 0.43081716 |
| 112 | PIK3CG | 0.42933894 |
| 113 | PTK2B | 0.42425580 |
| 114 | SGK3 | 0.41305474 |
| 115 | MAP2K2 | 0.40793497 |
| 116 | DYRK1B | 0.40283182 |
| 117 | RPS6KB2 | 0.38780190 |
| 118 | CDK12 | 0.38004655 |
| 119 | PRKCQ | 0.37899966 |
| 120 | PDK1 | 0.37191620 |
| 121 | RPS6KL1 | 0.37032407 |
| 122 | RPS6KC1 | 0.37032407 |
| 123 | PRKG2 | 0.36774742 |
| 124 | MYLK | 0.36076827 |
| 125 | CAMK1G | 0.35626515 |
| 126 | SIK3 | 0.35595916 |
| 127 | PRKCD | 0.34988098 |
| 128 | IGF1R | 0.34389508 |
| 129 | TIE1 | 0.34220228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.95124275 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69306948 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.52073961 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42704063 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20063161 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.07494082 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.95508083 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.91258508 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.88637366 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 1.85744098 |
| 11 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85104618 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83962182 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.80856768 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.78948297 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74233081 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72225875 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69043958 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66576488 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65208581 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.60478686 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57215016 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.55438557 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.52415037 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.51053814 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.50171459 |
| 26 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47622692 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45885893 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44312221 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.39079843 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38381623 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36145922 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32821144 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32176747 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.31524568 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31405726 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29698861 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25874337 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.22631119 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20400760 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18412987 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15903167 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15623042 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.13927225 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13908447 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12065571 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.11511904 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09946334 |
| 48 | * Hepatitis B_Homo sapiens_hsa05161 | 1.04697258 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03430396 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.02412767 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01252947 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.00328682 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99734237 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.98444871 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97630601 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93117477 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.92826686 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87668707 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85036494 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84355625 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82119705 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82101335 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.80905600 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80252869 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79697245 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.78043646 |
| 67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75233202 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74133083 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.72449213 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70918944 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69865521 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.68952529 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67907778 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67305387 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66511856 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.65670968 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65216752 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63381759 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63196317 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61615886 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59121515 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58345074 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.57795780 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56695407 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56305773 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55558975 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55425889 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55399420 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55306792 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54857671 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54129775 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53670626 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52779641 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52619985 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52078154 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50629886 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49442345 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47619690 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.47352527 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47123655 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47072669 |
| 102 | Bladder cancer_Homo sapiens_hsa05219 | 0.46330527 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.46044527 |
| 104 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45958616 |
| 105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44882523 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.44122715 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43346531 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42482674 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41743439 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40272937 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39011860 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38827410 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38215054 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36572167 |
| 115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36436371 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35322183 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34321186 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33773002 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32815422 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32802211 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32800274 |
| 122 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.32641343 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.32240414 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31333112 |
| 125 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31082281 |

